Male breast cancer

Nicole P. Sandhu, Marie Brid Mac Bride, Christina A. Dilaveri, Lonzetta Neal, David R. Farley, Charles Lawrence Loprinzi, Dietlind L. Wahner-Roedler, Karthik Ghosh

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Male breast cancer is rare, and many patients and health care providers are not familiar with this entity. Although the underlying causes are not well understood, certain populations are at higher risk, including certain gene mutation carriers, men with Klinefelter syndrome, and certain ethnic groups. Male breast cancer typically presents at a later stage than female breast cancer. A palpable mass is the most common presentation, but nipple discharge or other nipple changes may be seen. Because the number of affected individuals is small, prospective trials have not been conducted; thus, treatment recommendations are typically taken from large trials involving female breast cancer populations. Although outcomes in male breast cancer were previously thought to be worse than female breast cancer outcomes, it appears that they are similar. Questions regarding the most effective surgical and adjuvant therapies remain. Mastectomy with axillary lymph node evaluation, adjuvant hormonal therapy, and chemotherapy are commonly used. Providers of health care to male patients must be aware of the possibility of breast cancer and appropriately evaluate any suspicious changes.

Original languageEnglish (US)
Pages (from-to)146-153
Number of pages8
JournalJournal of Men's Health
Volume9
Issue number3
DOIs
StatePublished - Sep 2012

Fingerprint

Male Breast Neoplasms
Breast Neoplasms
Health Personnel
Klinefelter Syndrome
Nipples
Mastectomy
Ethnic Groups
Patient Care
Therapeutics
Lymph Nodes
Drug Therapy
Mutation
Population
Genes

Keywords

  • Breast neoplasms, male
  • Diagnosis
  • Disease management
  • Risk
  • Treatment outcome

ASJC Scopus subject areas

  • Medicine(all)
  • Urology

Cite this

Sandhu, N. P., Bride, M. B. M., Dilaveri, C. A., Neal, L., Farley, D. R., Loprinzi, C. L., ... Ghosh, K. (2012). Male breast cancer. Journal of Men's Health, 9(3), 146-153. https://doi.org/10.1016/j.jomh.2012.03.013

Male breast cancer. / Sandhu, Nicole P.; Bride, Marie Brid Mac; Dilaveri, Christina A.; Neal, Lonzetta; Farley, David R.; Loprinzi, Charles Lawrence; Wahner-Roedler, Dietlind L.; Ghosh, Karthik.

In: Journal of Men's Health, Vol. 9, No. 3, 09.2012, p. 146-153.

Research output: Contribution to journalArticle

Sandhu, NP, Bride, MBM, Dilaveri, CA, Neal, L, Farley, DR, Loprinzi, CL, Wahner-Roedler, DL & Ghosh, K 2012, 'Male breast cancer', Journal of Men's Health, vol. 9, no. 3, pp. 146-153. https://doi.org/10.1016/j.jomh.2012.03.013
Sandhu NP, Bride MBM, Dilaveri CA, Neal L, Farley DR, Loprinzi CL et al. Male breast cancer. Journal of Men's Health. 2012 Sep;9(3):146-153. https://doi.org/10.1016/j.jomh.2012.03.013
Sandhu, Nicole P. ; Bride, Marie Brid Mac ; Dilaveri, Christina A. ; Neal, Lonzetta ; Farley, David R. ; Loprinzi, Charles Lawrence ; Wahner-Roedler, Dietlind L. ; Ghosh, Karthik. / Male breast cancer. In: Journal of Men's Health. 2012 ; Vol. 9, No. 3. pp. 146-153.
@article{0b9c10760f5d4f8a9e97026a4a4ece96,
title = "Male breast cancer",
abstract = "Male breast cancer is rare, and many patients and health care providers are not familiar with this entity. Although the underlying causes are not well understood, certain populations are at higher risk, including certain gene mutation carriers, men with Klinefelter syndrome, and certain ethnic groups. Male breast cancer typically presents at a later stage than female breast cancer. A palpable mass is the most common presentation, but nipple discharge or other nipple changes may be seen. Because the number of affected individuals is small, prospective trials have not been conducted; thus, treatment recommendations are typically taken from large trials involving female breast cancer populations. Although outcomes in male breast cancer were previously thought to be worse than female breast cancer outcomes, it appears that they are similar. Questions regarding the most effective surgical and adjuvant therapies remain. Mastectomy with axillary lymph node evaluation, adjuvant hormonal therapy, and chemotherapy are commonly used. Providers of health care to male patients must be aware of the possibility of breast cancer and appropriately evaluate any suspicious changes.",
keywords = "Breast neoplasms, male, Diagnosis, Disease management, Risk, Treatment outcome",
author = "Sandhu, {Nicole P.} and Bride, {Marie Brid Mac} and Dilaveri, {Christina A.} and Lonzetta Neal and Farley, {David R.} and Loprinzi, {Charles Lawrence} and Wahner-Roedler, {Dietlind L.} and Karthik Ghosh",
year = "2012",
month = "9",
doi = "10.1016/j.jomh.2012.03.013",
language = "English (US)",
volume = "9",
pages = "146--153",
journal = "Journal of Men's Health and Gender",
issn = "1875-6867",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Male breast cancer

AU - Sandhu, Nicole P.

AU - Bride, Marie Brid Mac

AU - Dilaveri, Christina A.

AU - Neal, Lonzetta

AU - Farley, David R.

AU - Loprinzi, Charles Lawrence

AU - Wahner-Roedler, Dietlind L.

AU - Ghosh, Karthik

PY - 2012/9

Y1 - 2012/9

N2 - Male breast cancer is rare, and many patients and health care providers are not familiar with this entity. Although the underlying causes are not well understood, certain populations are at higher risk, including certain gene mutation carriers, men with Klinefelter syndrome, and certain ethnic groups. Male breast cancer typically presents at a later stage than female breast cancer. A palpable mass is the most common presentation, but nipple discharge or other nipple changes may be seen. Because the number of affected individuals is small, prospective trials have not been conducted; thus, treatment recommendations are typically taken from large trials involving female breast cancer populations. Although outcomes in male breast cancer were previously thought to be worse than female breast cancer outcomes, it appears that they are similar. Questions regarding the most effective surgical and adjuvant therapies remain. Mastectomy with axillary lymph node evaluation, adjuvant hormonal therapy, and chemotherapy are commonly used. Providers of health care to male patients must be aware of the possibility of breast cancer and appropriately evaluate any suspicious changes.

AB - Male breast cancer is rare, and many patients and health care providers are not familiar with this entity. Although the underlying causes are not well understood, certain populations are at higher risk, including certain gene mutation carriers, men with Klinefelter syndrome, and certain ethnic groups. Male breast cancer typically presents at a later stage than female breast cancer. A palpable mass is the most common presentation, but nipple discharge or other nipple changes may be seen. Because the number of affected individuals is small, prospective trials have not been conducted; thus, treatment recommendations are typically taken from large trials involving female breast cancer populations. Although outcomes in male breast cancer were previously thought to be worse than female breast cancer outcomes, it appears that they are similar. Questions regarding the most effective surgical and adjuvant therapies remain. Mastectomy with axillary lymph node evaluation, adjuvant hormonal therapy, and chemotherapy are commonly used. Providers of health care to male patients must be aware of the possibility of breast cancer and appropriately evaluate any suspicious changes.

KW - Breast neoplasms, male

KW - Diagnosis

KW - Disease management

KW - Risk

KW - Treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=84865169862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865169862&partnerID=8YFLogxK

U2 - 10.1016/j.jomh.2012.03.013

DO - 10.1016/j.jomh.2012.03.013

M3 - Article

AN - SCOPUS:84865169862

VL - 9

SP - 146

EP - 153

JO - Journal of Men's Health and Gender

JF - Journal of Men's Health and Gender

SN - 1875-6867

IS - 3

ER -